Thus, under a Q2W schedule when tumor burden is sufficiently low, BCMA-BsAb dimers are more likely to find an available CD3 receptor to bind and form a trimer, leading to better maintenance of response. This evidence concerns the gene TNFRSF17 and neoplasm.